Minerva Surgical Company Insiders

UTRS Stock  USD 0.0001  0.0001  50.00%   
Minerva Surgical employs about 174 people. The company is managed by 7 executives with a total tenure of roughly 406 years, averaging almost 58.0 years of service per executive, having 24.86 employees per reported executive. Breaking down Minerva Surgical's management performance can provide insight into the firm performance.
Joanne Long  Insider
VP Controller
Dominique Filloux  Insider
Chief Officer
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Minerva Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Minerva Surgical Management Team Effectiveness

The company has return on total asset (ROA) of (0.2735) % which means that it has lost $0.2735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6008) %, meaning that it created substantial loss on money invested by shareholders. Minerva Surgical's management efficiency ratios could be used to measure how well Minerva Surgical manages its routine affairs as well as how well it operates its assets and liabilities.
The market capitalization of Minerva Surgical is $13.14 Million. The majority of Minerva Surgical outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Minerva Surgical to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Minerva Surgical. Please pay attention to any change in the institutional holdings of Minerva Surgical as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in pink sheets such as Minerva Surgical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Minerva Surgical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Minerva Surgical Workforce Comparison

Minerva Surgical is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 506. Minerva Surgical totals roughly 174 in number of employees claiming about 34% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.

Minerva Surgical Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Minerva Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Minerva Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Minerva Surgical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Minerva Surgical Notable Stakeholders

A Minerva Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Minerva Surgical often face trade-offs trying to please all of them. Minerva Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Minerva Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
String symbol = request.getParameter("s");

About Minerva Surgical Management Performance

The success or failure of an entity such as Minerva Surgical often depends on how effective the management is. Minerva Surgical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Minerva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Minerva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Minerva Surgical operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 157 people.
Please note, the imprecision that can be found in Minerva Surgical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Minerva Surgical. Check Minerva Surgical's Beneish M Score to see the likelihood of Minerva Surgical's management manipulating its earnings.

Minerva Surgical Workforce Analysis

Traditionally, organizations such as Minerva Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Minerva Surgical within its industry.

Minerva Surgical Manpower Efficiency

Return on Minerva Surgical Manpower

Revenue Per Employee289K
Revenue Per Executive7.2M
Net Loss Per Employee196K
Net Loss Per Executive4.9M
Working Capital Per Employee125.5K
Working Capital Per Executive3.1M

Additional Tools for Minerva Pink Sheet Analysis

When running Minerva Surgical's price analysis, check to measure Minerva Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Surgical is operating at the current time. Most of Minerva Surgical's value examination focuses on studying past and present price action to predict the probability of Minerva Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Surgical's price. Additionally, you may evaluate how the addition of Minerva Surgical to your portfolios can decrease your overall portfolio volatility.